PAX6 gene intragenic deletions in Mexican patients with congenital aniridia

Molecular Vision

Volumn 12, Issue , 2006, Pages 318-323

  Ramirez Miranda, Arturo ^a   Zenteno, Juan Carlos ^a  

^a INSTITUTE OF OPHTHALMOLOGY CONDE DE VALENCIANA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TRANSCRIPTION FACTOR PAX6;

ADULT; ANIRIDIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; FOUNDER EFFECT; GENE AMPLIFICATION; GENE DELETION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GEOGRAPHY; HISPANIC; HUMAN; INTRON; MALE; MEXICO; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; STOP CODON; VISUAL SYSTEM EXAMINATION;

ADULT; ANIRIDIA; BASE SEQUENCE; CHILD; CODON; EXONS; EYE PROTEINS; FEMALE; FOUNDER EFFECT; GENE DELETION; HISPANIC AMERICANS; HOMEODOMAIN PROTEINS; HUMANS; INTRONS; MALE; MEXICO; MOLECULAR SEQUENCE DATA; PAIRED BOX TRANSCRIPTION FACTORS; REPRESSOR PROTEINS;

EID: 33645720646     PISSN: 10900535     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Graw J. The genetic and molecular basis of congenital eye defects. Nat Rev Genet 2003; 4:876-88.
2. Nilsson DE. Eye evolution: a question of genetic promiscuity. Curr Opin Neurobiol 2004; 14:407-14.
3. Simpson TI, Price DJ. Pax6; a pleiotropic player in development. Bioessays 2002; 24:1041-51.
4. Ashery-Padan R, Gruss P. Pax6 lights-up the way for eye development. Curr Opin Cell Biol 2001; 13:706-14.
5. Davis A, Cowell JK. Mutations in the PAX6 gene in patients with hereditary aniridia. Hum Mol Genet 1993; 2:2093-7.
6. Vincent MC, Gallai R, Olivier D, Speeg-Schatz C, Flament J, Calvas P, Dollfus H. Variable phenotype related to a novel PAX 6 mutation (IVS4+5G>C) in a family presenting congenital nystagmus and foveal hypoplasia. Am J Ophthalmol 2004; 138:1016-21.
7. Mirzayans F, Pearce WG, MacDonald IM, Walter MA. Mutation of the PAX6 gene in patients with autosomal dominant keratitis. Am J Hum Genet 1995; 57:539-48.
8. Glaser T, Jepeal L, Edwards JG, Young SR, Favor J, Maas RL. PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects. Nat Genet 1994; 7:463-71. Erratum in: Nat Genet 1994; 8:203.
9. Hanson IM, Fletcher JM, Jordan T, Brown A, Taylor D, Adams RJ, Punnett HH, van Heyningen V. Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nat Genet 1994; 6:168-73.
10. Azuma N, Yamaguchi Y, Handa H, Tadokoro K, Asaka A, Kawase E, Yamada M. Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations. Am J Hum Genet 2003; 72:1565-70.
11. Glaser T, Walton DS, Maas RL. Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nat Genet 1992; 2:232-9.
12. Tzoulaki I, White IM, Hanson IM. PAX6 mutations: genotypephenotype correlations. BMC Genet 2005; 6:27.
13. Li P, Bellows AB, Thompson JN. Molecular basis of iduronate-2-sulphatase gene mutations in patients with mucopolysaccharidosis type II (Hunter syndrome). J Med Genet 1999; 36:21-7.
14. Flanagan JG, Lefranc MP, Rabbitts TH. Mechanisms of divergence and convergence of the human immunoglobulin alpha 1 and alpha 2 constant region gene sequences. Cell 1984; 36:681-8.
15. Vilchis F, Ramos L, Kofman-Alfaro S, Zenteno JC, Mendez JP, Chavez B. Extreme androgen resistance in a kindred with a novel insertion/deletion mutation in exon 5 of the androgen receptor gene. J Hum Genet 2003; 48:346-51.
16. Hanson IM. PAX6 and congenital eye malformations. Pediatr Res 2003; 54:791-6.
17. Sale MM, Craig JE, Charlesworth JC, FitzGerald LM, Hanson IM, Dickinson JL, Matthews SJ, Heyningen V V, Fingert JH, Mackey DA. Broad phenotypic variability in a single pedigree with a novel 1410delC mutation in the PST domain of the PAX6 gene. Hum Mutat 2002; 20:322.
18. De Becker I, Walter M, Noel LP. Phenotypic variations in patients with a 1630 A>T point mutation in the PAX6 gene. Can J Ophthalmol 2004; 39:272-8.
19. Walther C, Gruss P. Pax-6, a murine paired box gene, is expressed in the developing CNS. Development 1991; 113:1435-49.
20. Sisodiya SM, Free SL, Williamson KA, Mitchell TN, Willis C, Stevens JM, Kendall BE, Shorvon SD, Hanson IM, Moore AT, van Heyningen V. PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet 2001; 28:214-6.
21. Free SL, Mitchell TN, Williamson KA, Churchill AJ, Shorvon SD, Moore AT, van Heyningen V, Sisodiya SM. Quantitative MR image analysis in subjects with defects in the PAX6 gene. Neuroimage 2003; 20:2281-90.
22. Mitchell TN, Free SL, Williamson KA, Stevens JM, Churchill AJ, Hanson IM, Shorvon SD, Moore AT, van Heyningen V, Sisodiya SM. Polymicrogyria and absence of pineal gland due to PAX6 mutation. Ann Neurol 2003; 53:658-63.
23. Aguiar PH, Liu CW, Leitao H, Issa F, Lepski G, Figueiredo EG, Gomes-Pinto F, Marino Junior R. MR and CT imaging in the Dyke-Davidoff-Masson syndrome. Report of three cases and contribution to pathogenesis and differential diagnosis. Arq Neuropsiquiatr 1998; 56:803-7.
24. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 1999; 96:307-10.
25. Singh S, Tang HK, Lee JY, Saunders GF. Truncation mutations in the transactivation region of PAX6 result in dominant-negative mutants. J Biol Chem 1998; 273:21531-41.
26. Duncan MK, Cvekl A, Li X, Piatigorsky J. Truncated forms of Pax-6 disrupt lens morphology in transgenic mice. Invest Ophthalmol Vis Sci 2000; 41:464-73.